New Key Statistics Module, Z-Score and F-Score
OTCPK:RGTLF Key Ratios
| Market Cap $ M | 9.05 |
| Enterprise Value $ M | 5.04 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 8.11 |
| Price/Sales | 1.15 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -2.15 |
| Beneish M-Score | -6.17 |
| 10-y EBITDA Growth Rate % | 9.90 |
| 5-y EBITDA Growth Rate % | -13.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.46 |
| EV-to-EBITDA | -0.49 |
| PEG | -- |
| Shares Outstanding M | 45.28 |
| Net Margin (%) | -1,020.20 |
| Operating Margin % | -944.42 |
| Pre-tax Margin (%) | -1,028.42 |
| Quick Ratio | 0.66 |
| Current Ratio | 0.76 |
| ROA % (ttm) | -119.95 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -86.32 |
| Dividend Yield % | -- |
| Altman Z-Score | -24.12 |
RGTLF Number of Guru Trades
RGTLF Volume of Guru Trades
Gurus Latest Trades with OTCPK:RGTLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RGTLF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Argent Biopharma Ltd Insider Transactions
No Available Data
News about OTCPK:RGTLF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers